239 related articles for article (PubMed ID: 18339830)
21. Perineal talc exposure and risk of ovarian carcinoma.
Chang S; Risch HA
Cancer; 1997 Jun; 79(12):2396-401. PubMed ID: 9191529
[TBL] [Abstract][Full Text] [Related]
22. Re: "Perineal powder exposure and the risk of ovarian cancer".
Muscat JE; Wynder EL
Am J Epidemiol; 1997 Nov; 146(9):786. PubMed ID: 9366627
[No Abstract] [Full Text] [Related]
23. Talc use and ovarian cancer: epidemiology between a rock and a hard place.
Wentzensen N; Wacholder S
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214563
[No Abstract] [Full Text] [Related]
24. Perineal powder use and risk of ovarian cancer.
Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
[TBL] [Abstract][Full Text] [Related]
25. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
[TBL] [Abstract][Full Text] [Related]
26. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Penninkilampi R; Eslick GD
Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
[TBL] [Abstract][Full Text] [Related]
27. Talc and anti-MUC1 antibodies.
Muscat J; Huncharek M; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2679; author reply 2680. PubMed ID: 16284398
[No Abstract] [Full Text] [Related]
28. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
29. Douching, Talc Use, and Risk of Ovarian Cancer.
Gonzalez NL; O'Brien KM; D'Aloisio AA; Sandler DP; Weinberg CR
Epidemiology; 2016 Nov; 27(6):797-802. PubMed ID: 27327020
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
31. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.
Ness RB; Grisso JA; Cottreau C; Klapper J; Vergona R; Wheeler JE; Morgan M; Schlesselman JJ
Epidemiology; 2000 Mar; 11(2):111-7. PubMed ID: 11021606
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of ovarian cancer development].
Horiuchi A; Konishi I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():597-600. PubMed ID: 15535315
[No Abstract] [Full Text] [Related]
33. Talc: need we beware?
Natow AJ
Cutis; 1986 May; 37(5):328-9. PubMed ID: 3754807
[No Abstract] [Full Text] [Related]
34. Talc and ovarian cancer.
Hartge P; Hoover R; Lesher LP; McGowan L
JAMA; 1983 Oct; 250(14):1844. PubMed ID: 6620481
[No Abstract] [Full Text] [Related]
35. Ovarian Cancer and "Tainted Talc": What Treating Physicians Need to Know.
Casey R; Larkin TP
Mo Med; 2019; 116(2):83-86. PubMed ID: 31040485
[No Abstract] [Full Text] [Related]
36. Perineal powder exposure and the risk of ovarian cancer.
Cook LS; Kamb ML; Weiss NS
Am J Epidemiol; 1997 Mar; 145(5):459-65. PubMed ID: 9048520
[TBL] [Abstract][Full Text] [Related]
37. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
Wentzensen N; O'Brien KM
Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
[TBL] [Abstract][Full Text] [Related]
38. Critical review of the association between perineal use of talc powder and risk of ovarian cancer.
Kadry Taher M; Farhat N; Karyakina NA; Shilnikova N; Ramoju S; Gravel CA; Krishnan K; Mattison D; Wen SW; Krewski D
Reprod Toxicol; 2019 Dec; 90():88-101. PubMed ID: 31472245
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of ovarian cancer].
Tamaya T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():435-40. PubMed ID: 15535283
[No Abstract] [Full Text] [Related]
40. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
